[HTML][HTML] Tandem autologous-autologous versus autologous-allogeneic hematopoietic stem cell transplant for patients with multiple myeloma: long-term follow-up …
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
[HTML][HTML] Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up …
S Giralt, LJ Costa, D Maloney, A Krishnan… - Biology of Blood and …, 2020 - astctjournal.org
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
[HTML][HTML] Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma: Long-term …
S Giralt, LJ Costa, D Maloney, A Krishnan… - Biology of blood and …, 2020 - ncbi.nlm.nih.gov
Allogeneic hematopoietic cell transplantation (HCT) may improve long-term multiple
myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a …
myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a …
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results …
S Giralt, LJ Costa, D Maloney, A Krishnan… - Biology of Blood and …, 2020 - experts.umn.edu
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
[HTML][HTML] Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up …
S Giralt, LJ Costa, D Maloney, A Krishnan… - Biology of Blood and …, 2020 - tctjournal.org
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results …
S Giralt, LJ Costa, D Maloney… - Biology of Blood …, 2020 - mdanderson.elsevierpure.com
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results …
S Giralt, LJ Costa, D Maloney, A Krishnan… - Biology of Blood and …, 2019 - europepmc.org
Allogeneic hematopoietic cell transplantation (HCT) may improve long-term multiple
myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a …
myeloma (MM) control through graft vs myeloma (GVM) effect. The BMT CTN 0102 was a …
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results …
S Giralt, LJ Costa, D Maloney… - Biology of blood …, 2020 - pubmed.ncbi.nlm.nih.gov
Allogeneic hematopoietic cell transplant (HCT) may improve long-term multiple myeloma
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …
(MM) control through the graft-versus-myeloma effect. The Blood and Marrow Transplant …